BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 32160908)

  • 1. MDC1 PST-repeat region promotes histone H2AX-independent chromatin association and DNA damage tolerance.
    Salguero I; Belotserkovskaya R; Coates J; Sczaniecka-Clift M; Demir M; Jhujh S; Wilson MD; Jackson SP
    Nat Commun; 2019 Nov; 10(1):5191. PubMed ID: 31729360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Targeted Therapy System for Cervical Cancer:  Co-Delivery System  of  Antisense LncRNA of MDC1 and Oxaliplatin Magnetic Thermosensitive Cationic Liposome Drug Carrier.
    Ye H; Chu X; Cao Z; Hu X; Wang Z; Li M; Wan L; Li Y; Cao Y; Diao Z; Peng F; Liu J; Xu L
    Int J Nanomedicine; 2021; 16():1051-1066. PubMed ID: 33603368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico study reveals unconventional interactions between MDC1 of DDR and Beclin-1 of autophagy.
    Pandya K; Singh N
    Mol Divers; 2023 Dec; 27(6):2789-2802. PubMed ID: 36482226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SND1 Promotes Radioresistance in Cervical Cancer Cells by Targeting the DNA Damage Response.
    Fu X; Duan Z; Lu X; Zhu Y; Ren Y; Zhang W; Sun X; Ge L; Yang J
    Cancer Biother Radiopharm; 2022 Mar; ():. PubMed ID: 35271349
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of RNA splicing associated with Wnt signaling pathway using FD-895 and pladienolide B.
    Kumar D; Kashyap MK; Yu Z; Spaanderman I; Villa R; Kipps TJ; La Clair JJ; Burkart MD; Castro JE
    Aging (Albany NY); 2022 Mar; 14(5):2081-2100. PubMed ID: 35230971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Falcarindiol Enhances Cisplatin Chemosensitivity of Hepatocellular Carcinoma
    Hong H; Jin Z; Qian T; Xu X; Zhu X; Fei Q; Yang J; Sui C; Xu M
    Front Pharmacol; 2021; 12():656697. PubMed ID: 34025420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles for MDC1 in cancer development and treatment.
    Ruff SE; Logan SK; Garabedian MJ; Huang TT
    DNA Repair (Amst); 2020 Nov; 95():102948. PubMed ID: 32866776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax.
    Goodarzi AA; Jeggo P; Lobrich M
    DNA Repair (Amst); 2010 Dec; 9(12):1273-82. PubMed ID: 21036673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells.
    Singh N; Bhakuni R; Chhabria D; Kirubakaran S
    BMC Res Notes; 2020 Mar; 13(1):146. PubMed ID: 32160908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.
    Folk WP; Kumari A; Iwasaki T; Pyndiah S; Johnson JC; Cassimere EK; Abdulovic-Cui AL; Sakamuro D
    J Biol Chem; 2019 Apr; 294(14):5700-5719. PubMed ID: 30733337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of fused toes homolog enhances cisplatin sensitivity in cervical cancer cells by inhibiting epidermal growth factor receptor-mediated repair of DNA damage.
    Subramanian PD; An Z; Yu JR; Park WY
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):753-62. PubMed ID: 27535835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional defects of cancer-associated MDC1 mutations in DNA damage repair.
    Xie R; Yan Z; Jing J; Wang Y; Zhang J; Li Y; Liu X; Yu X; Wu C
    DNA Repair (Amst); 2022 Jun; 114():103330. PubMed ID: 35378404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch1 inhibition enhances DNA damage induced by cisplatin in cervical cancer.
    Li S; Ren B; Shi Y; Gao H; Wang J; Xin Y; Huang B; Liao S; Yang Y; Xu Z; Li Y; Zeng Q
    Exp Cell Res; 2019 Mar; 376(1):27-38. PubMed ID: 30690027
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.